Health & Fitness

According to FutureWise analysis, the implantable medical devices market in 2025 is US$102.57 billion, and is expected to reach US$184.21 billion by 2033 at a CAGR of 7.59%. Implantable medical devices are inserted into the body either permanently or temporarily. They are used to monitor physiological processes, distribute medications, or support the functions of specific organs or tissues. Some implants serve as prosthetic replacements for damaged body parts. These devices may be made from various materials, including metals, polymers, ceramics, or human tissues. Active implantable medical devices require an external electrical energy source, rather than relying solely on the energy generated by the human body or gravity. Typically battery-operated, these devices are designed to remain inside the body after the surgical or medical implantation procedure. Common examples of implantable medical devices include artificial joints, breast implants, cochlear implants, intraocular ... Continue reading →

According to FutureWise analysis the Immune Thrombocytopenia (ITP) Market in 2025 is US$ 3.02 billion, and is expected to reach US$ 3.57 billion by 2033 at a CAGR of 2.11%. The market growth in Immune Thrombocytopenia reflects its chronic nature and the need for long-term management. Advancements in targeted therapies, such as thrombopoietin receptor agonists and immunomodulatory treatments, are improving patient outcomes. Increased awareness and earlier diagnosis are also driving demand for ITP therapies globally. Treatment strategies for Immune Thrombocytopenia (ITP) are personalized based on the severity of the disease, the risk of bleeding, and individual patient characteristics. First-line therapies generally include corticosteroids and intravenous immunoglobulin (IVIG), which help to reduce the immune-mediated destruction of platelets. For individuals with chronic or refractory ITP, second-line treatments may involve thrombopoietin receptor agonists, monoclonal antibodies, or ... Continue reading →

According to FutureWise analysis, the Implantable Neurostimulators market in 2025 is US$5.71 billion, and is expected to reach US$9.49 billion by 2033 at a CAGR of 6.56%.  The implantable neurostimulators market is on the rise, driven by a growing prevalence of chronic neurological disorders like Parkinson's disease, epilepsy, and persistent pain conditions. As we embrace the potential of neuromodulation therapies, the landscape is undergoing a remarkable transformation. Exciting innovations are leading this charge, with breakthroughs such as rechargeable devices, closed-loop systems, and MRI-compatible stimulators paving the way for enhanced therapeutic outcomes and significantly improving patients' quality of life. North America is at the forefront of this dynamic field, supported by a sophisticated healthcare infrastructure and favorable reimbursement policies. Meanwhile, Europe is experiencing robust growth, fueled by increased healthcare investments ... Continue reading →

According to FutureWise analysis, the In Silico Clinical Trials market in 2025 is US$3.58 billion, and is expected to reach US$6.36 billion by 2033 at a CAGR of 7.45%. The in silico clinical trials market is experiencing significant growth, driven by the pharmaceutical industry's need to reduce drug development costs and timelines. Computational modeling and simulation provide notable advantages over traditional clinical trial methods. Recent advancements in artificial intelligence, machine learning algorithms, and digital twin technologies are improving the accuracy and predictive capabilities of virtual trials. Regulatory agencies, including the FDA and EMA, are increasingly recognizing these methods and are offering guidance, which accelerates their adoption in drug discovery, medical device development, and personalized medicine applications. North America leads the market due to substantial R&D investments and the presence of major pharmaceutical companies. Meanwhile, the ... Continue reading →

According to FutureWise analysis, the immuno-oncology market in 2025 is US$32.45 billion, and is expected to reach US$124.9 billion by 2033 at a CAGR of 18.35%.The Immuno-Oncology market is experiencing rapid growth due to the increasing global burden of cancer and the rising success of immunotherapies, such as checkpoint inhibitors and CAR-T cell therapies. Advances in precision medicine and biomarker research are facilitating the development of more targeted and effective treatments. Strategic collaborations between biotech firms and pharmaceutical companies are accelerating the drug development process. Furthermore, regulatory approvals for novel therapies and expanded indications are contributing to market expansion across various cancer types. The increasing incidence of cancer, coupled with significant advancements in technology—especially in molecular techniques—has significantly impacted the landscape of cancer diagnostics. Extensive research initiatives and ... Continue reading →

According to FutureWise analysis, The In situ hybridization (ISH) market in 2025 is US$1.82 billion, and is expected to reach US$4.54 billion by 2033 at a CAGR of 12.10%. The in-situ hybridization market is on an impressive growth trajectory, largely propelled by the surging demand for accurate cancer diagnostics. A key area of emphasis is HER2 testing in breast cancer, along with companion diagnostics that enhance targeted therapies. Recent technological breakthroughs in fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH) are revolutionizing the field, boosting detection sensitivity and enabling multiplex analysis to identify genetic abnormalities with remarkable precision. But the excitement doesn’t stop there! The rising prevalence of genetic disorders and infectious diseases, coupled with expanding applications in areas like neuroscience research and drug development, is significantly expanding the market's horizons. North America ... Continue reading →

According to FutureWise analysis the Immunoadsorption Columns Market in 2025 is US$ 142.16 million, and is expected to reach US$ 318.9 million by 2033 at a CAGR of 10.63%. The growth in this market is fueled by the rise in autoimmune and neurological disorders, along with greater use of extracorporeal blood purification therapies. Immunoadsorption columns effectively eliminate pathogenic antibodies and immune complexes from blood, providing targeted treatment with fewer side effects than traditional plasma exchange. Advancements in column materials and broader clinical uses are also contributing to market growth. Immunoadsorption columns are advanced medical devices utilized in extracorporeal blood purification therapies to selectively eliminate pathogenic antibodies, immune complexes, and inflammatory mediators from a patient's bloodstream. These columns are engineered with highly specific adsorptive materials that bind to targeted immunoglobulins while preserving vital plasma ... Continue reading →

According to FutureWise analysis, the in vitro fertilization /IVF market in 2025 is US$0.91 billion, and is expected to reach US$1.77 billion by 2033 at a CAGR of 8.67%. The in vitro fertilization (IVF) market is experiencing significant growth due to several factors. Rising infertility rates globally, delayed childbearing resulting from lifestyle and career choices, and increasing social acceptance of assisted reproductive technologies are driving this expansion. Technological innovations, such as preimplantation genetic testing (PGT), time-lapse embryo imaging, and artificial intelligence-enhanced embryo selection, are improving success rates and reducing the number of treatment cycles needed. Additionally, the expansion of insurance coverage for fertility treatments in various countries, along with the rise of medical tourism in regions offering cost-effective IVF procedures, is further propelling market growth. Currently, Europe and North America dominate the IVF market due ... Continue reading →

According to FutureWise analysis, the In Vitro Lung Model Market in 2025 is US$0.52 billion, and is expected to reach US$1.46 billion by 2033 at a CAGR of 13.68%.  The In Vitro Lung Model Market is currently on an exciting trajectory of growth, driven by some compelling factors. At the forefront is the surge in innovative, non-animal testing methods that are revolutionizing the research landscape. As respiratory diseases become increasingly prevalent, the demand for effective research solutions is more urgent than ever. Pharmaceutical and biotech companies are eagerly seeking out advanced predictive drug screening platforms that can elevate their development processes. Meanwhile, groundbreaking technological advancements like organ-on-chip systems and 3D lung tissue models are opening new doors for more realistic and relevant research. These innovations are not only transforming our comprehension of toxicology and inhalation studies but are also fostering ... Continue reading →

According to FutureWise analysis, the In-Vitro Transcription Templates Market in 2025 is US$316.47 million, and is expected to reach US$1219 million by 2033 at a CAGR of 18.36%.  The In-Vitro Transcription Templates Market is on an exhilarating upward trajectory, largely propelled by the explosive growth of mRNA therapeutics and vaccines. This transformation has been particularly pronounced in the wake of the rapid innovations spurred by the COVID-19 pandemic. As the fields of synthetic biology and gene expression studies flourish, they are creating a vibrant demand in this ever-evolving market. North America is at the forefront, thanks to substantial investments in biotechnology research and a well-established pharmaceutical infrastructure. Industry pioneers are relentlessly innovating, crafting high-purity, scalable transcription templates that adhere to the rigorous standards necessary for both clinical and commercial applications. Moreover, the market is set to ... Continue reading →